{ "description": null, "compose": { "include": [ { "system": "http://www.ama-assn.org/go/cpt", "concept": [ { "code": "1012415", "display": "Flow cytometry, interpretation" }, { "code": "3170F", "display": "Flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)" }, { "code": "88184", "display": "Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; first marker" }, { "code": "88185", "display": "Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; each additional marker (List separately in addition to code for first marker)" }, { "code": "88187", "display": "Flow cytometry, interpretation; 2 to 8 markers" }, { "code": "88189", "display": "Flow cytometry, interpretation; 16 or more markers" } ] } ] }, "_filename": "ValueSet-2.16.840.1.113762.1.4.1116.508.json", "package_name": "us.nlm.vsac", "date": "2019-12-04T01:00:20-05:00", "meta": { "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ], "versionId": "12", "lastUpdated": "2023-04-03T13:49:33.000-04:00" }, "publisher": "CancerLinQ Steward", "jurisdiction": [ { "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/data-absent-reason", "valueString": "UNKNOWN" } ] } ], "purpose": "(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )", "name": "FlowCytometryStudiesPerformed", "type": null, "experimental": "false", "resourceType": "ValueSet", "expansion": { "total": 6, "offset": 0, "contains": [ { "code": "1012415", "system": "http://www.ama-assn.org/go/cpt", "display": "Flow cytometry, interpretation", "version": "2023" }, { "code": "3170F", "system": "http://www.ama-assn.org/go/cpt", "display": "Baseline flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)", "version": "2023" }, { "code": "88184", "system": "http://www.ama-assn.org/go/cpt", "display": "Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; first marker", "version": "2023" }, { "code": "88185", "system": "http://www.ama-assn.org/go/cpt", "display": "Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; each additional marker (List separately in addition to code for first marker)", "version": "2023" }, { "code": "88187", "system": "http://www.ama-assn.org/go/cpt", "display": "Flow cytometry, interpretation; 2 to 8 markers", "version": "2023" }, { "code": "88189", "system": "http://www.ama-assn.org/go/cpt", "display": "Flow cytometry, interpretation; 16 or more markers", "version": "2023" } ], "parameter": [ { "name": "count", "valueInteger": 1000 }, { "name": "offset", "valueInteger": 0 } ], "timestamp": "2023-09-26T10:29:20-04:00", "identifier": "urn:uuid:fa9fecef-35a2-4d4c-992e-8478ab02e5fc" }, "title": "Flow Cytometry Studies Performed", "package_version": "0.12.0", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueString": "CancerLinQ Author" }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2022-12-15" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2023-04-03" } ], "status": "active", "id": "9daaf900-6f60-49c1-abaa-b324aaf153bb", "kind": null, "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.508", "identifier": [ { "value": "urn:oid:2.16.840.1.113762.1.4.1116.508", "system": "urn:ietf:rfc:3986" } ], "version": "20191204" }